| Outcomes of men aged ≥60 years old with moderately elevated PSA (1–20 ng/mL) in the PLCO cancer screening trial |
Scott Eggener |
University of California, Los Angeles |
PLCO |
Oct 5, 2026 |
PLCO-2084 |
| Incidence of Upper Tract Urothelial Carcinoma in Relation to Smoking, Analgesic Use, and Medical History in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial |
Jonathan Hofmann |
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health |
PLCO |
Sep 28, 2026 |
PLCO-2085 |
| Quantitative Analysis of H&E Histopathology and Cancer Outcomes in PLCO |
James Kelley |
Pictor Labs. Inc. |
PLCO |
Sep 28, 2026 |
PLCOI-2081 |
| Analytical Suitability and Storage-Stability Pilot for a Serum NMR-Based Multi-Omics Multi-Cancer Early Detection Assay Using Pre-Diagnostic PLCO Specimens |
PATRICK STRASSER |
Wholomics GmbH |
PLCO |
Sep 15, 2026 |
2026-0185 |
| The Population Attributable Fractions of Pancreatic Cancer Caused by Key Risk Factors (continuation of PLCO-351) |
Rachael Stolzenberg-Solomon |
NCI, NIH |
PLCO |
Sep 10, 2026 |
PLCO-2083 |
| Quantifiable TCR repertoire changes in pre-diagnostic blood specimens among high-grade ovarian cancer patients |
Bo Li |
Children's Hospital of Philadelphia |
PLCO |
Sep 10, 2026 |
2025-0079 |
| Integration of omics data and lifestyle factors to assess lung cancer risk among former smokers |
Xiao Ou Shu |
Vanderbilt University Medical Center |
PLCO |
Sep 10, 2026 |
2025-0054 |
| Prostate Cancer Risk Stratification Using Needle Core Biopsy or Radical Prostatectomy Specimens (Continuation of PLCOI-2074) |
Uttara Joshi |
AIRA Matrix Private Limited |
PLCO |
Sep 8, 2026 |
PLCOI-2080 |
| Evaluating the Impact of Differential LDCT Screening Uptake, Adherence, and Novel Treatment Access on Racial/Ethnic Disparities in Lung Cancer Outcomes: A Modeling Study |
Michael Leo |
Oregon Health & Science University |
PLCO |
Sep 8, 2026 |
PLCO-2072 |
| Artificial Intelligence (AI)-Assisted Health Informatics to Stratify Population for Early Screening of Cancer (Sibling Project to PLCO-2067) |
Gregory Hart |
University of Guam |
PLCO |
Aug 31, 2026 |
PLCO-2078 |
| Evaluate Artera’s Deep Learning clinical-histologic system as a prognostic classifier for colorectal cancer patients |
Douglas Peters |
Artera Inc. |
PLCO |
Aug 24, 2026 |
PLCOI-2073 |
| External Validation of Foundation Model-Derived Histologic Phenotypes in Prostate Pathology Images |
Olmo Zavala Romero |
Florida State University |
PLCO |
Aug 24, 2026 |
PLCOI-2063 |
| Digital Twin–Enabled Prediction of Toxicity and Tumor Control in Prostate Cancer Radiotherapy |
Samantha Rincon Sabatino |
InfotechSoft |
PLCO |
Aug 24, 2026 |
PLCOI-2075 |
| Machine Learning to Refine Breast Staging for Prediction of Axillary Node Status and Prognosis |
Mark Sherman |
Mayo Clinic, Jacksonville, Florida |
PLCO |
Aug 10, 2026 |
PLCOI-2066 |
| Virtual Staining–Enabled Macrophage Profiling in Ovarian & Lung Cancer |
Anant Madabhushi |
Emory University |
PLCO |
Jul 27, 2026 |
PLCOI-2068 |
| Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of mortality in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial |
Fiona Malcomson |
Newcastle University |
PLCO |
Jul 27, 2026 |
PLCO-2069 |
| AEGIS — AI-Enabled Genomic and Integrated Stratification for Multi-Cancer Risk: Deep-Learning Development and Internal Validation in the PLCO Cohort |
Aneel Paulus |
West Eastern Health |
PLCO |
Jul 14, 2026 |
PLCO-2064 |
| Development of generalizable pathology foundation models for cancer prognosis using PLCO whole slide images |
Marvin Lerousseau |
Spotlight Medical, SAS |
PLCO |
Jul 14, 2026 |
PLCOI-2060 |
| External Validation of a Deep-Learning Atypical Mitosis Based Prognostic Model Using the PLCO Pathology Image Repository |
William Chen |
University of California, San Francisco |
PLCO |
Jul 14, 2026 |
PLCOI-2059 |
| Developing a risk prediction model for future colorectal neoplasia |
AASMA SHAUKAT |
NYU Langone Health |
PLCO |
Jul 14, 2026 |
PLCOI-2062 |
